期刊文献+

雌激素受体基因多态性与2型糖尿病患者骨密度的关系 被引量:12

Relationship between estrogen receptor gene polymorphism and bone mineral density in type 2 diabetic patients
暂未订购
导出
摘要 目的探讨雌激素受体(ER)基因多态性与2型糖尿病患者骨密度(BMD)的相关性。方法运用双能量X线吸收法(DEXA)测定61例2型糖尿病患者的BMD,PCR-RFLP检测ER基因多态性。结果2型糖尿病组PP型的BMD与Pp型相比,在L2,L3,L4及L2~4有显著的统计学差异(P值分别为0.045,0.021,0.019和0.019);与pp型相比,在L4有显著的统计学差异(P=0.037)。Pp型与pp型相比,各部位BMD均无显著的统计学差异。ER基因型分布频率为PP型0.128,pp型0.333,Pp型0.539,PP型腰椎BMD明显低于Pp型与pp型。结论2型糖尿病易合并骨量减少和骨质疏松,ER基因PP型与2型糖尿病患者腰椎低BMD密切相关。 Aim To investigate the relationship between estrogen receptor (ER) gene polymorphism and bone mineral density (BMD) in type 2 diabetes mellitus patient s(T2DM). Methods The BMD and ER gene polymorphism were measured by using dual en ergy X-ray absorptiometry (DEXA) in 61 patients with T2DM,25 males and 36 postm enopausal females with an average age of 56 years.Results Compared with Pp type patients with T2DM,the BMD of L2, L3, L4 and L2-4 in PP type patients with T2DM showed significantly statistical differences(P=0.045,0.021,0.019 and 0.019 resp ectively).Compared with pp type patients withT2DM, the BDM of L4 showed a signif icantly statistical difference(P=0.037). There were not significantly different in the BMD between Pp type and pp type.The distributing frequencies of ER gene p olymorphism were 0.128 in PP type patients,0.333 in pp type and 0.539 in Pp type respectively.The BMD of lumbar vertebrae in PP type was significantly lower tha n that in Pp type and pp type.Conclusion T2DM patient is the high-risk group of bone diminution and osteoporosis. ER gene polymorphism is closely related with the lower BMD of lumbar vertebrae in patients with type 2 DM.
出处 《中国临床康复》 CSCD 2003年第15期2140-2141,共2页 Chinese Journal of Clinical Rehabilitation
关键词 雌激素受体 基因多态性 2型糖尿病 骨密度 相关性 receptors, estrogen diabetes mellitus, non-insulin- department bone density densitometry x-ray polymerase chain reaction
  • 相关文献

参考文献2

二级参考文献14

  • 1黄晓青 邓春发.减肥治疗对肥胖患者血糖、胰岛素的影响[J].现代康复,2001,5(2):111-111.
  • 2SOWERS MF,KSHIRSAGAR A,CRUTCHFIELD MM,et al.Joint influence of fat and lean body composition compartments on femoral bone mineral density in premenopausal women[J].Am J Epidemiol,1992,136(3):257- 265.
  • 3ALBALA C,YANEZ M,DEVOTO E,et al.Obesity as a protective factor for postmenopausal osteoporosis[J].Int J Obes Metab Disord,1996,20(11):1027- 1032.
  • 4BLAAUW R,ALBERTSE EC,HOUGH S.Body fat distribution as a risk factor for osteoporosis[J].S Afr Med J,1996,86(9):1081- 1084.
  • 5KOBAYASHI S, INOVE S, HOSOI T, et al. Association of bone mineral density with polymorphism of the estrogen receptor gene[J]. J Bone Miner Res, 1996, 11:306- 311.
  • 6SAMBROOK J. Molecular cloning: a laboratory manual[M]. 3rd ed. New York: Cold Spring Harbor Laboratory, 1989:931- 958.
  • 7SALAMONE L, WOLF R, BLACK D, et al. Association between bone mineral density and the estrogen receptor genotype in premenopausal women[J]. J Bone Miner Res, 1999,14(suppl 1):SA097.
  • 8KIM SW, KIM CH, CHUNG YE, et al. The association of quantitative ultrasound parameters of the calcaneus with vitamin D receptor gene and estrogen receptor gene polymorphism in Korean postmenopausal women[J]. J Bone Miner Res, 2000,15 (suppl 1):SU 107.
  • 9BORI Z, SPEER G, TAKACS I, et al. Interactive effect of vitamin D and estradiol receptor genotype as a depterminant of bone mineral density[J]. J Bone Miner Res, 1999, 14(suppl 1):SA100.
  • 10GOSDEN JR,MIDDLEZON PG,ROUT D. Localization of the human estrogen receptor gene to chromosome 6 q24- q27 by in situ hybridization[J].Cytogenet Cell Genet, 1986,43(3):218- 220.

共引文献18

同被引文献171

引证文献12

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部